Staphylococcal superantigens cause lethal pulmonary disease in rabbits

Journal of Infectious Diseases

Volumn 202, Issue 11, 2010, Pages 1690-1697

  Strandberg, Kristi L ^a   Rotschafer, Jessica H ^a   Vetter, Sara M ^a   Buonpane, Rebecca A ^b   Kranz, David M ^b   Schlievert, Patrick M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS ENTEROTOXIN C; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; TOXIC SHOCK SYNDROME TOXIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HISTOPATHOLOGY; LETHALITY; LUNG DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RABBIT;

ANIMALS; BACTERIAL TOXINS; DISEASE MODELS, ANIMAL; ENTEROTOXINS; LUNG DISEASES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 78649558101     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/657156     Document Type: Article

References (41)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-532.
2. Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002; 186:1344-1347.
3. Klevens RM, Morrison MA, Nadle J, et al. Invasivemethicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-1771.
4. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. JAMA 1999; 282:1123-1125.
5. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248:705-711.
6. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 2001; 55:77-104.
7. Li H, Llera A, Malchiodi EL, Mariuzza RA. The structural basis of T cell activation by superantigens. Annu Rev Immunol 1999; 17:435-466.
8. Wang L, Zhao Y, Li Z, et al. Crystal structure of a complete ternary complex of TCR, superantigen and peptide-MHC. Nat Struct Mol Biol 2007; 14:169-171.
9. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248:1066.
10. Schlievert PM. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1986; 1:1149-1150.
11. Schlievert PM, Tripp TJ, Peterson ML. Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. J Clin Microbiol 2004; 42:2875-2876.
12. Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 2010; 125:39-49.
13. Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194:1761-1770.
14. O'Reilly M, Kreiswirth B, Foster TJ. Cryptic alpha-toxin gene in toxic shock syndrome and septicaemia strains of Staphylococcus aureus. Mol Microbiol 1990; 4:1947-1955.
15. Blomster-Hautamaa DA, Schlievert PM. Preparation of toxic shock syndrome toxin-1. Methods Enzymol 1988; 165:37-43.
16. Blomster-Hautamaa DA, Kreiswirth BN, Novick RP, Schlievert PM. Resolution of highly purified toxic-shock syndrome toxin 1 into two distinct proteins by isoelectric focusing. Biochemistry 1986; 25:54-59.
17. Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis 1981; 143:509-516.
18. Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990; 17:251-272.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
20. Schlievert PM, Case LC, Nemeth KA, et al. Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins. Biochemistry 2007; 46:14349-14358.
21. Schlievert PM, Osterholm MT, Kelly JA, Nishimura RD. Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann Intern Med 1982; 96:937-940.
22. Schlievert PM, Bettin KM, Watson DW. Effect of antipyretics on group A streptococcal pyrogenic exotoxin fever production and ability to enhance lethal endotoxin shock. Proc Soc Exp Biol Med 1978; 157:472-475.
23. Schlievert PM, Gahr PJ, Assimacopoulos AP, et al. Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis. Infect Immun 1998; 66:218-223.
24. Hay FC, Olwyn MR. Practical Immunology. Oxford: Blackwell, 1980.
25. Buonpane RA, Churchill HR, Moza B, et al. Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nat Med 2007; 13:725-729.
26. Reed LJ, Muench H. A simple method of estimating 50 per cent endpoints. Am J Hyg 1938; 27.
27. Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13:16-34.
28. Sriskandan S, Moyes D, Buttery LK, et al. Streptococcal pyrogenic exotoxin A release, distribution, and role in a murine model of fasciitis and multiorgan failure due to Streptococcus pyogenes. J Infect Dis 1996; 173:1399-1407.
29. Giantonio BJ, Alpaugh RK, Schultz J, et al. Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibodystaphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer. J Clin Oncol 1997; 15:1994-2007.
30. Dinges MM, Gregerson DS, Tripp TJ, McCormick JK, Schlievert PM. Effects of total body irradiation and cyclosporin A on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome. J Infect Dis 2003; 188:1142-1145.
31. Dinges MM, Schlievert PM. Comparative analysis of lipopolysaccharide- induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1. Infect Immun 2001; 69:7169-172.
32. Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13:16-34.
33. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007; 13:1405-1406.
34. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315:1130-1133.
35. Dinges MM, Jessurun J, Schlievert PM. Comparisons of mouse and rabbit models of toxic shock syndrome. International Congress and Symposium Series 1998; 229:167-168.
36. Dinges MM, Schlievert PM. Comparative analysis of lipopolysaccharide- induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1. Infect Immun 2001; 69:7169-7172.
37. Sriskandan S, Unnikrishnan M, Krausz T, Cohen J. Molecular analysis of the role of streptococcal pyrogenic exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes. Mol Microbiol 1999; 33:778-790. (Pubitemid 29392658)
38. Fey PD, Said-Salim B, Rupp ME, et al. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47:196-203.
39. Schlievert PM. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J Allergy Clin Immunol 2001; 108:S107-S110.
40. Barry W, Hudgins L, Donta ST, Pesanti EL. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 1992; 267:3315-3316.
41. Holm SE, Kohler W, Kaplan EL, et al. Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation. Adv Exp Med Biol 1997; 418:193-199.